Juul Labs, Inc., Marketing, Sales Practices, and Products Liability Litigation
The causation theory in MDL-2913 is supported by scientific evidence indicating that Juul aerosols exhibit higher pulmonary toxicity compared to earlier-generation e-cigarettes, with studies showing oxidative stress, inflammation, and DNA damage caused by inhaled aerosols containing nicotine salts and flavor chemicals. High nicotine concentrations in Juul pods (equivalent to about 20 cigarettes per pod) are linked to adverse cardiovascular effects, including increased heart rate and blood pressure. Long-term inhalation has been associated with pulmonary inflammation and chronic respiratory diseases. Regulatory agencies like the FDA have issued warnings about the health risks of Juul, emphasizing its potential to cause addiction and harm, which underpin the causation claims.
11
Pending actions
7,071
Total actions filed
Active
Status
10/02/2019
Established
Who qualifies
Plaintiffs must provide detailed personal histories through Plaintiff Fact Sheets, including Juul usage duration, frequency, and medical diagnoses. While specific quantitative thresholds (e.g., exact nicotine dosage or usage duration) are not publicly detailed, the PFS collects comprehensive data to support individual assessments. Plaintiffs are required to demonstrate that they suffered injuries such as lung damage, cardiovascular problems, seizures, strokes, or nicotine addiction, with a plausible causal link to Juul use.
Products involved
- Juul e-cigarette devices
- Juul pods (Virginia Tobacco, Menthol)
- Nicotine salts
Alleged injuries
- lung injuries
- cardiovascular issues
- seizures
- strokes
- nicotine addiction
This page is generated from the official JPML pending-MDL report and public court records, refreshed monthly. It is provided for attorney reference and is not legal advice.
